Santen Ventures
Overview
Santen Ventures is the corporate venture capital arm of Santen Pharmaceutical, which invests globally in early-stage companies developing technologies and innovations in ophthalmology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| i-Lumen Scientific | Sep 2025 | Series B | Co-investor |
| TearSolutions | Dec 2017 | Series B | Co-investor |
| Aramis Biosciences, Inc. | Dec 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Santen Ventures based?
Santen Ventures is headquartered in Emeryville, California, United States.
When was Santen Ventures founded?
Santen Ventures was founded in 2017.
How many portfolio companies does Santen Ventures have?
Santen Ventures has 3 portfolio companies in Caplight's dataset.
What are some companies in Santen Ventures's portfolio?
Portfolio companies visible on Caplight include i-Lumen Scientific, TearSolutions, Aramis Biosciences, Inc..
What was Santen Ventures's most recent investment shown here?
Santen Ventures's most recent investment in this portfolio sample was in i-Lumen Scientific in 2025.
What sectors does Santen Ventures focus on?
Santen Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Santen Ventures focus on?
Santen Ventures typically invests at the Mid stage.